ELEPHAS BIOSCIENCES AND TES PHARMA COLLABORATE TO ADVANCE TRANSLATIONAL RESEARCH FOR LUNG CANCER THERAPY

Tes Pharma Will Use the elive™ Platform to Functionally Evaluate Response to TES-4207 in Live Tumor Fragments as a Monotherapy and in Combination With Immune Checkpoint Inhibitors MADISON, Wis., Sept. 24, 2026 /PRNewswire/ -- Elephas Biosciences Corporation, developer of a functional...